Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacqueline Bromberg

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Tris (dibenzylideneacetone) dipalladium, a N-myristoyltransferase-1 inhibitor, is effective against melanoma growth in vitro and in vivoSulochana S Bhandarkar, Jacqueline Bromberg, Carol Carrillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Increased dose density is feasible: a pilot study of adjuvant epirubicin and cyclophosphamide followed by paclitaxel, at 10- or 11-day intervals with filgrastim support in women with breast cancerMonica N Fornier, Andrew D Seidman, Diana Lake, et al.
Cancer Research|December 28, 2013
Oligodendrocyte progenitor cells promote neovascularization in glioma by disrupting the blood-brain barrierYujie Huang, Caitlin Hoffman, Prajwal Rajappa, et al.
Cancer Research|March 3, 2006
Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3Kenneth Leslie, Cynthia Lang, Geeta Devgan, et al.
Plos One|December 6, 2011
Stat3 mediates expression of autotaxin in breast cancerJaneen Azare, Ashley Doane, Kenneth Leslie, et al.
Research Square|June 17, 2024
Intratumoral Fc-optimized agonistic CD40 antibody induces tumor rejection and systemic antitumor immunity in patients with metastatic cancerJuan C Osorio, David A Knorr, Polina Weitzenfeld, et al.
Oncogene|April 18, 2002
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesisGuilian Niu, Kenneth L Wright, Mei Huang, et al.
Clinical Breast Cancer|April 23, 2018
Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast CancerPatrick G Morris, Selene Rota, Karen Cadoo, et al.
Cancer Cell|August 15, 2025
Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancerJuan C Osorio, David A Knorr, Polina Weitzenfeld, et al.
Biology|September 28, 2021
Pilot Study of Anti-Th2 Immunotherapy for the Treatment of Breast Cancer-Related Upper Extremity LymphedemaBabak J Mehrara, Hyeung Ju Park, Raghu P Kataru, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Tris (dibenzylideneacetone) dipalladium, a N-myristoyltransferase-1 inhibitor, is effective against melanoma growth in vitro and in vivoSulochana S Bhandarkar, Jacqueline Bromberg, Carol Carrillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Increased dose density is feasible: a pilot study of adjuvant epirubicin and cyclophosphamide followed by paclitaxel, at 10- or 11-day intervals with filgrastim support in women with breast cancerMonica N Fornier, Andrew D Seidman, Diana Lake, et al.
Cancer Research|December 28, 2013
Oligodendrocyte progenitor cells promote neovascularization in glioma by disrupting the blood-brain barrierYujie Huang, Caitlin Hoffman, Prajwal Rajappa, et al.
Cancer Research|March 3, 2006
Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3Kenneth Leslie, Cynthia Lang, Geeta Devgan, et al.
Plos One|December 6, 2011
Stat3 mediates expression of autotaxin in breast cancerJaneen Azare, Ashley Doane, Kenneth Leslie, et al.
Research Square|June 17, 2024
Intratumoral Fc-optimized agonistic CD40 antibody induces tumor rejection and systemic antitumor immunity in patients with metastatic cancerJuan C Osorio, David A Knorr, Polina Weitzenfeld, et al.
Oncogene|April 18, 2002
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesisGuilian Niu, Kenneth L Wright, Mei Huang, et al.
Clinical Breast Cancer|April 23, 2018
Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast CancerPatrick G Morris, Selene Rota, Karen Cadoo, et al.
Cancer Cell|August 15, 2025
Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancerJuan C Osorio, David A Knorr, Polina Weitzenfeld, et al.
Biology|September 28, 2021
Pilot Study of Anti-Th2 Immunotherapy for the Treatment of Breast Cancer-Related Upper Extremity LymphedemaBabak J Mehrara, Hyeung Ju Park, Raghu P Kataru, et al.
Pageof 6